Abstract
Drug device combination is defined as the combination of drugs and medical
devices that can be chemically or physically united or co-packaged as
separate, cross labeled products. The commercialization cycle from R&D to
product shows the immense potential of bundled offering. Currently, the market
has a potential of US$10.6 billion and has been experiencing a growth of 15%
CAGR for past two years. In the next five years, the market is expected to
grow at a CAGR of 11.8%.
Untapped market potential and benefits are the primary factors for the early
adoption. The other market factors contributing are relatively shortened
product approval time with the establishment of Office of Combination Products
(OCP) within the FDA. An increase in the number of cardiovascular patient
population has also facilitated the early acceptance of the drug device
combination products. This is supported by the fact that cardiovascular
applications constitute about 64% of the entire drug-device combination
applications market. A future view of the drug-device combination is that
these next generation products will make single component medical devices
obsolete.
Europe and the U.S. hold major share of the global drug-device combination
market. The growth of the market in these countries is driven by growing
ageing population and improvements in medical science and biotechnology that
enables new product development. The emerging economies such as the BRIC
(Brazil, Russia, India, China) nations also represent a high growth potential
in this developing market.
Market estimates and forecast
- The report provides in-depth market estimates and forecasts for the global
weight management market. The segmentation is as follows:
Drug device combination - products
- Antimicrobial catheter, advanced wound care products, bone graft
substitutes, antibiotic bone cements, drug eluting stents, photodynamic
therapy, closed loop glucose monitor and insulin pump, steroid eluting
electrodes and others.
Drug device combination - application
- Bone treatment, cancer treatment, diabetes treatment, skin care treatment,
antimicrobial applications, urological treatment, non cardiovascular
treatment, cardiovascular treatment, ophthalmic treatment, others.
Drug device combination - technology
Each section will provide market data, market drivers, trends and
opportunities, top-selling products, key players, and competitive outlook.
This report will also provide more than 100 market tables for various
geographic regions covering the sub-segments and micro-markets. In addition,
the report also provides 50 company profiles for each of its sub-segments.
What makes our reports unique?
- We provide the longest market segmentation chain in this industry- not
many reports provide market breakdown upto level 5.
- Each report is about 250 pages with 100+ market data tables, 40
competitive company profiles,
| 
View Cart
